Myriad Genetics reported $800K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Accelerate Diagnostics AXDX:US USD 97K 17K
Agilent A:US USD 3M 0
Becton, Dickinson and BDX:US USD 365M 0
Bio Rad Laboratories BIO:US USD 3K 0
Bruker BRKR:US USD 1.7M 0
Danaher DHR:US USD 9M 0
Exact Sciences EXAS:US USD 1.77M 5K
Fluidigm FLDM:US USD 79K 0
Hologic HOLX:US USD 3M 0
Illumina ILMN:US USD 2M 0
Mettler Toledo International MTD:US USD 448K 0
Myriad Genetics MYGN:US USD 800K 0
Nanostring Technologies NSTG:US USD 5K 0
Orasure Technologies OSUR:US USD 0 0
Pacific Biosciences Of California PACB:US USD 226K 1000
Perkinelmer PKI:US USD 126.22M 2K
Quest Diagnostics DGX:US USD 2M 0
Repligen RGEN:US USD 555K 0
Veracyte VCYT:US USD 72K 0
Waters WAT:US USD 1.62M 1000